Le Lézard
Classified in: Health
Subjects: WOM, DEI

New Semaglutide Weight Loss Injection Program in Philadelphia Announced by Lux Skin Lasers by John Lee, MD and Renowned Women's Wellness Physician Dr. Joseph Castelli


Lux Skin & Lasers announces the launch of their medical weight loss program with esteemed physician Dr. Joseph Castelli. The program incorporates the sought after and effective semaglutide (active ingredient in Ozempic and Wegovy) and Tirzapetide (active ingredient in Mounjaro) injection program in both their Bryn Mawr and King of Prussia location. The program features personalized monthly visits with Dr. Castelli along with affordability. Customized options include access to Tirzepatide for tailored treatment plans and membership benefits. Dr. Castelli reaffirms his excitement to provide the highest quality of care and effectiveness among medspa providers in the Philadelphia region.

KING OF PRUSSIA, Pa., May 6, 2024 /PRNewswire-PRWeb/ -- Dr. Joseph Castelli, an OBN/GYN and Women's health doctor with over three decades of providing exceptional care for his patients, proudly announces the launch of a comprehensive semaglutide weight loss injection program at Lux Skin Lasers, a medspa located in Bryn Mawr and King of Prussia, outside of Philadelphia. Dr. Castelli's dedication to innovation and patient care continues to set new standards in the field, offering an effective treatment plan for managing health and wellness.

"Through our new semaglutide injection weight loss program, I want to provide my patients with accessible and personalized medical care from someone who can assure their safety while helping them achieve their wellness goals with confidence and affordability," says Dr. Joseph Castelli.

Collaborating closely with his esteemed colleague Dr. John Lee within the practice, Dr. Castelli ensures that each client receives personalized attention and care. In contrast to industry norms, clients have the privilege of meeting directly with Dr. Castelli rather than a physician assistant or nurse practitioner, enhancing the quality and depth of their healthcare experience.

One of the standout features of Dr. Castelli's program is its affordability. Unlike other practices in the area where patients may be seen by PA/NP's and charged exorbitant fees, Dr. Castelli's program offers complimentary consultations to ensure that every patient is a good candidate for the program and there are no underlying medical to the treatment.

The hallmark of Lux's weight loss program is its affordability. Dr. Castelli commitment to providing access to as many people as possible so people to gain more self-confidence while also improving their weight is something that Lux and Dr. Castelli is excited about. He is thrilled to see his patients elated at their progress and their health improving. After an initial complimentary consultation, clients will return to review blood work with Dr. Castelli and start the program. Dr. Castelli will inject the first treatment of semaglutide or tirzapetide, a groundbreaking medication for managing weight loss and other various health conditions. He will also instruct clients on how to perform the treatment at home on a weekly basis for three more weeks. Their pricing model stands in stark contrast to the higher rates charged by most med spas in the vicinity without the level of care that Dr. Castelli and his team affords.

Moreover, Dr. Castelli's practice goes beyond mere affordability by offering a range of effective treatment options tailored to each client's needs. While semaglutide proves effective weight loss for most patients, Dr. Castelli also provides access to Tirzepatide (Mounjaro) for those who require alternative solutions. Priced competitively, this additional option ensures that every client receives a customized plan designed to optimize their weight loss goals.

"Through our new semaglutide injection weight loss program, I want to provide my patients with accessible and personalized medical care from someone who can assure their safety while helping them achieve their wellness goals with confidence and affordability," says Dr. Joseph Castelli.

As part of their commitment to comprehensive care, Lux Skin & Lasers by John Lee, MD practice extends weight loss membership benefits that include discounts on other premium services such as Botox, fillers, Coolsculpting and laser treatments. By prioritizing affordability and accessibility without compromising on quality, Dr. Castelli and his team reaffirm their reputation as the leading medspa in Mainline and in the Philadelphia region.

More about Dr. Joseph Castelli:

Dr. Joseph Castelli is an Aesthetic Doctor practicing at Lux Skin Lasers in Bryn Mawr and King of Prussia, PA, just outside Philadelphia. Dr. Castelli's commitment to excellence in patient care and innovation has earned him recognition as a leading figure in the medical community. To schedule a consultation, please call (610) 789-6701 or visit http://www.luxskinlasers.com.

Media Contact

Christina Kim, Lux Skin Lasers By John Lee MD, (610) 789-6701, [email protected], https://www.luxskinlasers.com/ 

SOURCE Lux Skin Lasers By John Lee MD


These press releases may also interest you

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

18 mai 2024
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...



News published on and distributed by: